MolNFT v1 · #406082 · protein
AlphaFold monomer V2.0 prediction for 30S ribosomal protein S4 (B7MCR2)
B7MCR2: “AlphaFold monomer V2.0 prediction for 30S ribosomal protein S4 (B7MCR2)”. 3 pockets (best druggability 0.60). MolNFT v1 #406082 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- Accession
- B7MCR2
- Type
- protein
- Length
- 206 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0x0c3BD61770FeF3aB621008259DC933f6DfDc3882
- Molecule
- 30S ribosomal protein S4
- UniProt
- B7MCR2
- Pockets
- 3 · best druggability 0.60
Structure
1 distinct chain · 43% helix, 9% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | 30S ribosomal protein S4 | protein | 206 | 43% helix, 9% strand | B7MCR2 |
Pockets
3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 116 | 0.60 | 0.86 | 22 | empty |
| 2 | 242 | 0.59 | 0.79 | 43 | empty |
| 3 | 88 | 0.33 | 0.74 | 17 | empty |
Compared structures
- 5WF0 · 70S ribosome-EF-Tu H84A complex with GTP and near-cognate tRNA (Complex C2) · an experimental structure of the same protein · chain A against d, TM-score 0.96
- 5WFS · 70S ribosome-EF-Tu H84A complex with GTP and near-cognate tRNA (Complex C4) · an experimental structure of the same protein · chain A against d, TM-score 0.96
- 5UZ4 · The cryo-EM structure of yjeq bound to the 30S subunit suggests a fidelity checkpoint… · an experimental structure of the same protein · chain A against D, TM-score 0.94
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt B7MCR2
- Elsewhere: UniProt B7MCR2 · AlphaFold DB B7MCR2
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.